TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors
Amit Dipak Amin(Sylvester Comprehensive Cancer Center), Jonathan H. Schatz(Memorial Sloan Kettering Cancer Center)
Cited by 22
Related Papers
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
|The Journal of Experimental Medicine|2011|114